These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6136013)

  • 1. Trimethyltin induced changes of neurotransmitter levels and brain receptor binding in the mouse.
    Ali SF; Cranmer JM; Goad PT; Slikker W; Harbison RD; Cranmer MF
    Neurotoxicology; 1983; 4(1):29-36. PubMed ID: 6136013
    [No Abstract]   [Full Text] [Related]  

  • 2. Time course alterations in tremor and muscarinic receptor binding produced by trimethyltin.
    Slikker W; Ali SF; Lipscomb J; Denton R
    Proc West Pharmacol Soc; 1985; 28():139-42. PubMed ID: 4070238
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinergic and dopaminergic alterations in the mouse central nervous system following acute trimethyltin exposure.
    Ali SF; Slikker W; Newport GD; Goad PT
    Acta Pharmacol Toxicol (Copenh); 1986 Sep; 59(3):179-88. PubMed ID: 2879410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s).
    Harden TK; Scheer AG; Smith MM
    Mol Pharmacol; 1982 May; 21(3):570-80. PubMed ID: 6287196
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the energy status of the brain structures in pharmacological exposures].
    Arkhipov VI; Bulantsev AIu
    Farmakol Toksikol; 1986; 49(3):115-9. PubMed ID: 2873050
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphological changes in the salivary glands upon stimulation by receptor-selective agonists. II. Submandibular glands of the mouse.
    Vreugdenhil AP; de Lange GL; Nieuw Amerongen AV; Roukema PA
    J Biol Buccale; 1980 Mar; 8(1):73-86. PubMed ID: 6102562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobehavioral toxicology of trialkyltins.
    McMillan DE; Wenger GR
    Pharmacol Rev; 1985 Dec; 37(4):365-79. PubMed ID: 2872688
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antidepressive agents: classification and mechanism of action].
    Cuenca E; Alamo C; Coullaut-Jáuregui J
    Rev Clin Esp; 1997 Nov; 197 Suppl 3():44-7. PubMed ID: 9477690
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible influence of noradrenaline on beta-adrenergic and muscarinic cholinergic receptors in rat heart: effects of 6-hydroxydopa, isoproterenol, and desmethylimipramine.
    Nomura Y; Kajiyama H; Segawa T
    Adv Biochem Psychopharmacol; 1983; 36():83-90. PubMed ID: 6305158
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of repeated administration of desmethylimipramine on beta adrenergic and muscarinic cholinergic receptors and 45Ca++ binding to sarcoplasmic reticulum in the rat heart.
    Nomura Y; Kajiyama H; Oki K
    J Pharmacol Exp Ther; 1982 Dec; 223(3):834-40. PubMed ID: 6292402
    [No Abstract]   [Full Text] [Related]  

  • 11. Morphological changes in the salivary glands upon stimulation by receptor-selective agonists. I. Parotid glands of the mouse.
    Vreugdenhil AP; de Lange GL; Nieuw Amerongen AV; Roukema PA
    J Biol Buccale; 1980 Mar; 8(1):59-71. PubMed ID: 6154049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in cardiac autonomic receptors following 6-hydroxydopamine treatment in rats.
    Yamada S; Yamamura HI; Roeske WR
    Mol Pharmacol; 1980 Sep; 18(2):185-92. PubMed ID: 6252437
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphological changes in the salivary glands upon stimulation by receptor-selective agonists. III. Sublingual glands of the mouse.
    Vreugdenhil AP; de Lange GL; Nieuw Amerongen AV; Roukema PA
    J Biol Buccale; 1980 Mar; 8(1):87-98. PubMed ID: 6102563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice.
    Rabin RA; Wolfe BB; Dibner MD; Zahniser NR; Melchior C; Molinoff PB
    J Pharmacol Exp Ther; 1980 Jun; 213(3):491-6. PubMed ID: 6259318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Ethylmaleimide-induced alteration in the interaction of agonists with muscarinic cholinergic receptors of rat brain.
    Korn SJ; Martin MW; Harden TK
    J Pharmacol Exp Ther; 1983 Jan; 224(1):118-26. PubMed ID: 6294274
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective neurochemical and histological lesions in rat hippocampus following chronic trimethyltin exposure.
    Valdes JJ; Mactutus CF; Santos-Anderson RM; Dawson R; Annau Z
    Neurobehav Toxicol Teratol; 1983; 5(3):357-61. PubMed ID: 6136003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species and strain comparison of acute neurotoxic effects of trimethyltin in mice and rats.
    Chang LW; Wenger GR; McMillan DE; Dyer RS
    Neurobehav Toxicol Teratol; 1983; 5(3):337-50. PubMed ID: 6877475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of activation of alpha- and beta-adrenergic receptors, M-cholinergic receptors and H1-histamine receptors on mechanical tension in the frog subclavian vein].
    Protas LL; Sysoev VV; Leont'eva GR
    Biull Eksp Biol Med; 1983 Jan; 95(1):58-60. PubMed ID: 6131707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of antidepressants at the synapse: focus on newer compounds.
    Richelson E
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():34-9; discussion 40-1, 98-100. PubMed ID: 7961541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.